Clinical Trial Update: Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation [Phase 4]

View source ↗

Summary

Phase 4 trial updating safety and immunogenicity of Zostavax vaccine in patients undergoing living donor kidney transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• Zostavax (Varicella zoster vaccine live)

Snippet

Sponsor: University of Alberta | Conditions: Kidney Transplant | Phase 4 | Status: COMPLETED